Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,766.90
(
0.11%
)
News Focus
News Focus
Post# of 4930
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Tha Part Time Er

Send PM Follow Ignore
Followers 90
Posts 3296
Boards Moderated 0
Alias Born 10/18/2010

Tha Part Time Er

Re: Tha Part Time Er post# 3508

Tuesday, 04/28/2020 8:05:48 AM

Tuesday, April 28, 2020 8:05:48 AM

Post# of 4930
Japan on board with Gilead's remdesivir, approval expected in May
Apr. 27, 2020 9:18 AM ETGilead Sciences, Inc. (GILD)77 Comments
Gilead Sciences (NASDAQ:GILD) perks up 1% premarket on light volume on the heels of a statement from Japan's Prime Minister Shinzo Abe that health authorities intend to approve antiviral remdesivir next month for the treatment of COVID-19.
Once the company files its application, the Japanese government is set to fast track review and approval. A clinical trial there should wind up in this week.


Uhhhhh ohhhhhh $$$$$$$$ More Positive NEWS here!!!!!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GILD News
More GILD News